An investigation about the antithrombotic therapy in the hospitalized patients with atrial fibrillation
10.3760/cma.j.issn.1008-6706.2015.24.017
- VernacularTitle:心房颤动住院患者抗栓治疗分析
- Author:
Ying BAI
;
Jiawei WANG
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Thrombophilia;
Therapeutics
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(24):3732-3735
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the conditions of antithrombotic therapy in patients with atrial fibrillation (AF)and provide reference for clinical rational use of drugs.Methods The clinical data of 1 69 hospitalized patients with AF from July 201 4 to September 201 4 in Beijing Tongren Hospital affiliated to Capital Medical University were retrospectively analyzed.The risk stratification for thromboembolism,types of AF,drug selection,drug combination and adverse reactions were analyzed.Results In 1 69 patients with AF,the proportion of valvular AF was 1 4.20%(24 /1 69)and non -valvular AF was 85.80%(1 45 /1 69),the patients with AF aged over 60 years old accounted for 84.62%.In the antithrombotic therapy,warfarin accounted for 94.87% (74 /78),the average daily dosage was (2.51 4 ±0.842)mg,the cases with INR between 2.0 to 3.0 accounted for 41 .89%(31 /74).The incidence rate of adverse reactions was 2.56%(2 /78).Conclusion The antithrombotic therapy is obviously insufficient,the clinical pharmacists should analyze the factors which influence the treatment and promote the rational use of antithrombotic therapy in AF patients.
